In late 2025, Meta Platforms agreed to acquire Manus for approximately $2–2.5 billion, aiming to accelerate its push into autonomous AI agents, a key frontier in generative AI.
However, in April 2026, Chinese regulators, led by the National Development and Reform Commission (NDRC), ordered the deal to be unwound, effectively blocking the acquisition even after it had been signed and partially integrated.
This represents a rare and significant instance of ex-post intervention in a completed cross-border M&A transaction.
Company Profiles
Meta Platforms
- A U.S.-based technology conglomerate operating platforms such as Facebook, Instagram, and WhatsApp
- Increasingly repositioning itself as an AI-first company, investing heavily in generative AI, infrastructure, and agent-based systems
- The Manus acquisition was part of a strategy to shortcut internal development by acquiring a functional AI agent platform with commercial traction.
Manus
- An AI startup originally developed in China (via Beijing-based roots) and later incorporated in Singapore
- Focus: general-purpose autonomous AI agents capable of executing complex, multi-step tasks (e.g., research, planning, workflow automation)
- Reportedly achieved rapid commercialization, including ~$100 million annualized revenue
- Maintained deep links to Chinese talent, IP, and founding team despite relocation
Strategically, Manus represented a high-value AI application layer asset, not just a research lab, making it particularly sensitive.
Regulatory Intervention: What Happened?
Chinese authorities:
- Conducted a national security review beginning shortly after the deal announcement
- Prevented founders from leaving China during the investigation
- Ultimately ordered Meta to unwind the acquisition entirely
The ruling applies despite:
- Manus being headquartered in Singapore
- The deal already being signed and partially executed
This reflects an expanded jurisdictional doctrine, China asserting authority over companies with:
- Chinese-origin IP
- Chinese founders or talent
- Strategic technology exposure
Core Reasons Behind the Block
National Security and Strategic Technology Protection
The primary justification cited was national security.
Chinese authorities view AI, especially autonomous agents, as:
- A dual-use technology (civilian + military applications)
- A critical input into future economic and geopolitical competitiveness
Allowing a U.S. acquirer to control such assets raises concerns about:
- Transfer of sensitive algorithms and data
- Loss of AI talent and know-how
- Strategic dependency
Control Over Chinese-Origin Technology (Even Offshore)
A decisive factor was Manus’s Chinese origin, despite relocation to Singapore.
Regulators effectively signaled:
- Offshore restructuring does not remove Chinese regulatory reach
- Chinese-founded AI firms remain subject to domestic scrutiny
This reflects a broader policy stance:
Chinese tech assets, especially in AI, are treated as national strategic resources, regardless of domicile.
Prevention of “Technology Leakage” to the U.S.
The deal was viewed as enabling:
- Transfer of AI capabilities to a U.S. platform
- Integration into Meta’s global ecosystem
China is increasingly:
- Restricting outbound flows of advanced technology and talent
- Mirroring U.S. restrictions (e.g., export controls, CFIUS reviews)
Escalating U.S.–China Tech Rivalry
The intervention must be read in the context of:
- Intensifying AI arms race
- Reciprocal restrictions on capital, chips, and data
The Manus decision signals:
- A shift toward economic securitization of M&A
- Increased politicization of cross-border tech deals
Regulatory Non-Compliance (Procedural Trigger)
Reports indicate the acquisition may have:
- Proceeded without prior Chinese approval, despite triggering review thresholds
This provided regulators with:
- A legal basis to intervene
- Leverage to impose a full unwind
M&A Implications
Expansion of Extraterritorial Review Risk
China is effectively asserting:
- Extraterritorial jurisdiction over tech assets
- A doctrine similar to U.S. outbound investment controls
Implication:
Dealmakers must assess “China nexus risk” even for offshore entities.
Rise of “Unwind Risk” Post-Closing
Traditionally, regulatory risk is pre-closing.
This case demonstrates:
- Deals can be retroactively invalidated
- Integration risk becomes material
Structuring Challenges for AI Transactions
Future cross-border AI deals may require:
- Ring-fencing of IP and data
- Local governance structures
- Minority or partnership-based investments instead of full acquisitions
Chilling Effect on Venture and Growth Capital
The decision may:
- Discourage foreign investment in Chinese-origin AI startups
- Push founders to choose geopolitical alignment early
Strategic Takeaways
- AI is now a protected asset class
Comparable to semiconductors or defense technology in regulatory sensitivity - Jurisdiction is no longer geographic, it’s relational
Talent, IP origin, and data flows determine oversight - Cross-border M&A in tech is entering a bifurcated regime
Firms may need to operate in parallel ecosystems (U.S. vs China) - Execution risk in M&A has materially increased
Regulatory intervention can now:- Delay
- Restructure
- Or fully unwind transactions
The blocked Meta–Manus transaction is not an isolated regulatory action, it is a structural signal. China is formalizing a policy stance that AI capabilities with domestic roots cannot be transferred to foreign control, even indirectly.
For M&A practitioners, this marks a transition from traditional antitrust review toward sovereignty-driven deal scrutiny, where geopolitical alignment is as important as valuation, synergy, or strategic fit.